Witnessing the stock’s movement on the chart, on Thursday, Edwards Lifesciences Corp (NYSE: EW) set off with pace as it heaved 0.96% to $83.48, before settling in for the price of $82.69 at the close. Taking a more long-term approach, EW posted a 52-week range of $64.89-$84.66.
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was -2.36%. Meanwhile, its Annual Earning per share during the time was -2.36%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 3.99%. This publicly-traded company’s shares outstanding now amounts to $587.90 million, simultaneously with a float of $575.04 million. The organization now has a market capitalization sitting at $49.01 billion. At the time of writing, stock’s 50-day Moving Average stood at $77.54, while the 200-day Moving Average is $75.10.
Edwards Lifesciences Corp (EW) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Medical Devices industry. Edwards Lifesciences Corp’s current insider ownership accounts for 2.05%, in contrast to 86.97% institutional ownership. Preceding that transaction, on Aug 25 ’25, Company’s CVP, TMTT sold 2,500 for 81.95, making the whole transaction’s value amount to 204,865. This particular insider is now the holder of 30,996 in total.
Edwards Lifesciences Corp (EW) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.67 per share during the current fiscal year.
Edwards Lifesciences Corp’s EPS increase for this current 12-month fiscal period is 3.99% and is forecasted to reach 2.82 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 9.29% through the next 5 years, which can be compared against the -2.36% growth it accomplished over the previous five years trading on the market.
Edwards Lifesciences Corp (NYSE: EW) Trading Performance Indicators
Let’s observe the current performance indicators for Edwards Lifesciences Corp (EW). It’s Quick Ratio in the last reported quarter now stands at 3.87. Alongside those numbers, its PE Ratio stands at $56.99, and its Beta score is 1.03. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 8.62. Similarly, its price to free cash flow for trailing twelve months is now 83.37.
In the same vein, EW’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 1.46, a figure that is expected to reach 0.62 in the next quarter, and analysts are predicting that it will be 2.82 at the market close of one year from today.
Technical Analysis of Edwards Lifesciences Corp (EW)
Going through the that latest performance of [Edwards Lifesciences Corp, EW]. Its last 5-days volume of 7.76 million indicated improvement to the volume of 4.54 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 87.42% While, its Average True Range was 82.08.
Raw Stochastic average of Edwards Lifesciences Corp (EW) in the period of the previous 100 days is set at 90.45%, which indicates a major rise in contrast to 90.45% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 2.10 that was higher than 1.64 volatility it exhibited in the past 100-days period.
